RaQualia Pharma Inc.

¥573.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4579Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 3.70%
Div yield —
ROE 2.28%
Biotechnology
Beta (5Y) 0.85
PE TTM 90.59
TSR TTM 7.91%
Mkt cap ¥14.92B
ROIC 2.20%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥638
11.30%
(33.70%)
Sell 7|0|1|10|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
6.49
6.90
7.52
8.24
30.45%
26.43%
27.33%
40.09%
Revenue¥B
1.914
1.865
1.811
1.915
12.91%
6.34%
(2.35%)
4.53%
Peers (US$94.71M)
Cap (US$)
PE
83.60M
—
Capital
TTM
5Y
10Y
Leveragex
0.327
0.168
0.148
EBIT/Intx
2.050
1.470
1.081
Own earn%
(86.77)
(64.47)
(92.85)
Sh yield%
24.16
24.21
24.87
Owners
Insiders/Inst%
1.86
64.46
Short interest%
2.56
SBC / revenue%
0.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
18–23
$1 testx
0.0
Incr. ROIC%
40